INITIATIVES THAT IMPACT PRICING AND REIMBURSEMENT OF ORPHAN (AND ULTRA ORPHAN) DRUGS: REVIEW OF EUROPEAN TRENDS

被引：1
|
作者：
Rousseau, B. [1 ]
Poinas, A. [1 ]
Oliver, L. [1 ]
Collings, H. [1 ]
机构：
[1] Adelphi Values Ltd, Bollington, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1787
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP251
引用
收藏
页码：A695 / A696
页数：2
相关论文
共 50 条
  • [11] EVIDENCE REQUIREMENTS FOR PRICING AND REIMBURSEMENT DECISION MAKING FOR ORPHAN DRUGS IN ASIA
    Tan, S.
    Dummett, H.
    Kirpekar, S.
    Guan, Q.
    Priest, V. L.
    VALUE IN HEALTH, 2012, 15 (07) : A621 - A622
  • [12] ANALYSIS OF FUNDING CONDITIONS FOR ORPHAN MEDICINES IN SPAIN: TRENDS IN PRICING & REIMBURSEMENT
    Orchard, M.
    VALUE IN HEALTH, 2024, 27 (12) : S362 - S363
  • [13] ANALYSIS OF ORPHAN DRUGS REIMBURSEMENT IN MAJOR EUROPEAN HTA AGENCIES
    Houzelot, D.
    Heng, C.
    Perinaud, A.
    VALUE IN HEALTH, 2016, 19 (07) : A602 - A602
  • [14] TOP 20 ORPHAN DRUGS AVAILABILITY, PRICING AND REIMBURSEMENT IN SLOVAKIA: 2005-2012 REVIEW
    Babela, R.
    Uraz, V
    Babelova, O.
    Slezakova, Z.
    VALUE IN HEALTH, 2014, 17 (07) : A540 - A541
  • [15] Orphan Drug Pricing and Cost Trends in USA: An Analysis of Impact of Orphan Drug ACT
    Mishra, Sangita
    Prakash, Venkatesh Madhugiri
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2023, 57 (01) : S1 - S6
  • [16] THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE
    Nixon, F.
    VALUE IN HEALTH, 2008, 11 (06) : A375 - A376
  • [17] REIMBURSEMENT OF ORPHAN DRUGS: WHAT IS THE DIFFERENCE?
    Mueller, E.
    Schmidt, E.
    Ehreth, J.
    VALUE IN HEALTH, 2012, 15 (07) : A311 - A311
  • [18] ULTRA ORPHAN AND CANCER DRUG PRICING TRENDS IN THE US AND THE UK
    Aggarwal, S.
    Topaloglu, H.
    Kumar, S.
    VALUE IN HEALTH, 2015, 18 (07) : A547 - A547
  • [19] MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS
    Malacan, J.
    Gabriel, S.
    Dinet, J.
    Forget, S.
    Borget, I
    VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
  • [20] Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison
    Lee, Jong Hyuk
    HEALTHCARE, 2021, 9 (03)
12345